Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS

OBJECTIVE: To investigate the effect of different natalizumab washout (WO) periods on recurrence of MRI and clinical disease activity in patients switching from natalizumab to fingolimod. METHODS: In this multicenter, double-blind, placebo-controlled trial (TOFINGO), patients with relapsing-remittin...

全面介紹

Na minha lista:
書目詳細資料
發表在:Neurology
Main Authors: Kappos, Ludwig, Radue, Ernst-Wilhelm, Comi, Giancarlo, Montalban, Xavier, Butzkueven, Helmut, Wiendl, Heinz, Giovannoni, Gavin, Hartung, Hans-Peter, Derfuss, Tobias, Naegelin, Yvonne, Sprenger, Till, Mueller-Lenke, Nicole, Griffiths, Sarah, von Rosenstiel, Philipp, Gottschalk, Rebecca, Zhang, Ying, Dahlke, Frank, Tomic, Davorka
格式: Artigo
語言:Inglês
出版: Lippincott Williams & Wilkins 2015
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4501941/
https://ncbi.nlm.nih.gov/pubmed/26024899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001706
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍